Quarterly report [Sections 13 or 15(d)]

Stockholders' Equity (Details)

v3.25.1
Stockholders' Equity (Details)
3 Months Ended
Apr. 07, 2025
shares
Mar. 12, 2025
USD ($)
$ / shares
shares
Oct. 17, 2024
Mar. 31, 2025
USD ($)
$ / shares
shares
Dec. 31, 2024
$ / shares
shares
Oct. 31, 2024
shares
Oct. 07, 2024
$ / shares
Dec. 31, 2023
$ / shares
shares
Dec. 16, 2020
$ / shares
shares
Stockholders' Equity                  
Preferred stock authorized (in shares)           2,000,000   2,000,000  
Preferred stock, par value (in dollars per share) | $ / shares               $ 0.0001  
Temporary equity, shares authorized       2,213.8044 2,213.8044 2,213.8044      
Temporary equity, shares issued       2,213.8044 2,213.8044        
Temporary equity, shares outstanding       2,213.8044 2,213.8044        
Dividends payable | $       $ 1,770,767          
Common stock authorized (in shares)       43,000,000 43,000,000       43,000,000
Common stock, par value (in dollars per share) | $ / shares       $ 0.0001 $ 0.0001       $ 0.0001
Net proceeds from issuance of common stock | $       $ 4,372,378          
Preferred Stock Excluding Series A and Series A-1 Non-Voting Convertible Preferred Stock                  
Stockholders' Equity                  
Preferred stock authorized (in shares)       1,997,502 1,997,786        
Preferred stock, par value (in dollars per share) | $ / shares       $ 0.0001 $ 0.0001        
Preferred stock issued (in shares)       0 0        
Preferred stock outstanding (in shares)       0 0        
Series A Non-Voting Convertible Preferred Stock                  
Stockholders' Equity                  
Percentage of original shares remaining issued and outstanding       30.00%          
Shares automatically converted       10,000          
Preferred Stock                  
Stockholders' Equity                  
Preferred stock dividend rate percentage       5.00%          
Preferred stock dividend payment period       180 days          
Preferred Stock | Subsequent event                  
Stockholders' Equity                  
Preferred stock dividend payment period 180 days                
PIK dividend, shares 55.345                
Series A1 Convertible Preferred Stock                  
Stockholders' Equity                  
Preferred stock authorized (in shares)       284.2638 0        
Preferred stock, par value (in dollars per share) | $ / shares   $ 0.0001              
Preferred stock issued (in shares)       284.2638 0        
Preferred stock outstanding (in shares)       284.2638 0        
Minimum percentage of Preferred stock issued and outstanding       30.00%          
No. of share issued during conversion   10,000   10,000          
Pharmagesic Holdings Inc.                  
Stockholders' Equity                  
Preferred stock, par value (in dollars per share) | $ / shares             $ 0.0001    
Number of Contingent Value Rights Issuable for each Common Share     1            
Contingent value rights agreement term     7 years            
Percentage of upfront payment to which holders are entitled     87.75%            
Percentage ownership of outstanding rights that entitles holder to audit and enforcement     30.00%            
Registered Direct Offering                  
Stockholders' Equity                  
Shares issued   578,950              
Price per share | $ / shares   $ 8.26              
Gross proceeds from issuance of shares | $   $ 4,780,000              
Net proceeds from issuance of common stock | $   $ 4,250,000